Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Abdominal Aortic Aneurysm Inhibition (MAAAGI)
2024-517387-37-00Phase 2Authorised
- Sponsor
- Uppsala University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Metformin 2 g daily with Placebo (2 arms). Primary endpoint: Primary endpoint: Change in CT-assessed AAA diameter. Planned start Nov 2024; status: authorised.
02
Drugs
metformin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2024-517387-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517387-37-00.